A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment intensification can meaningfully improve survival for patients with ...

Prostate-specific antigen (PSA) is a protein produced by both normal and cancerous cells in the prostate gland. It is primarily measured through a blood test, where normal levels are typically found ...

A newly developed long-term prediction model demonstrated greater accuracy in estimating prostate cancer–specific mortality compared with existing risk assessment tools. Unlike traditional ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

An article about the importance of PSA testing for early detection and treatment of prostate cancer ...

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...

Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

When is the last time the men in your life had a real talk about their health? Seeing as September is Prostate Cancer Awareness Month, it’s a good time to start the conversation. Prostate cancer cases ...